LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Therapy Development Turn Biotechnologies is developing a powerful reprogramming therapy aimed at addressing multiple aging-related indications. This advanced technology can potentially open up sales opportunities in the anti-aging market segment.

Strategic Partnerships Recent global licensing agreements with HanAll Biopharma demonstrate Turn Bio's focus on strategic partnerships for developing novel eye and ear therapies. These collaborations present sales prospects for the company in expanding its product offerings and market reach.

Key Personnel Additions The hiring of industry veterans like Richard 'Ric' Peterson as the chief financial officer and Vittorio Sebastiano as the head of research showcases Turn Bio's commitment to strengthening its leadership team. This can enhance the company's credibility and potentially attract new business opportunities.

Cutting-Edge Technology Platform Turn Bio's platform utilizes mRNA technology to develop novel medicines to combat age-related diseases. This innovative approach can position the company as a frontrunner in the biotechnology research sector and create avenues for sales growth through differentiated product offerings.

Untapped Market Potential With a focus on developing treatments for age-related diseases and a revenue range of $0-$10M, Turn Biotechnologies operates in a market segment with significant growth potential. By leveraging its unique therapies and scientific advancements, the company can explore untapped sales opportunities within the burgeoning healthcare industry.

Similar companies to Turn Biotechnologies

Turn Biotechnologies Tech Stack

Turn Biotechnologies uses 8 technology products and services including jQuery CDN, Squarespace, Google Font API, and more. Explore Turn Biotechnologies's tech stack below.

  • jQuery CDN
    Content Delivery Network
  • Squarespace
    Content Management System
  • Google Font API
    Font Scripts
  • Choices
    Javascript Libraries
  • Open Graph
    Miscellaneous
  • RSS
    Miscellaneous
  • Google
    Miscellaneous
  • YouTube
    Video Players

Media & News

Turn Biotechnologies's Email Address Formats

Turn Biotechnologies uses at least 1 format(s):
Turn Biotechnologies Email FormatsExamplePercentage
First.Last@turn.bioJohn.Doe@turn.bio
49%
First.L@turn.bioJohn.D@turn.bio
1%
First.Last@turn.bioJohn.Doe@turn.bio
49%
First.L@turn.bioJohn.D@turn.bio
1%

Frequently Asked Questions

Where is Turn Biotechnologies's headquarters located?

Minus sign iconPlus sign icon
Turn Biotechnologies's main headquarters is located at 319 North Bernardo Ave Mountain View, California 94043 US. The company has employees across 2 continents, including North AmericaEurope.

What is Turn Biotechnologies's official website and social media links?

Minus sign iconPlus sign icon
Turn Biotechnologies's official website is turn.bio and has social profiles on LinkedIn.

How much revenue does Turn Biotechnologies generate?

Minus sign iconPlus sign icon
As of September 2024, Turn Biotechnologies's annual revenue reached $1.8M.

What is Turn Biotechnologies's SIC code NAICS code?

Minus sign iconPlus sign icon
Turn Biotechnologies's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Turn Biotechnologies have currently?

Minus sign iconPlus sign icon
As of September 2024, Turn Biotechnologies has approximately 29 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: A. K.Chief Financial Officer: R. P.Head Of Immunology: M. T.. Explore Turn Biotechnologies's employee directory with LeadIQ.

What industry does Turn Biotechnologies belong to?

Minus sign iconPlus sign icon
Turn Biotechnologies operates in the Biotechnology Research industry.

What technology does Turn Biotechnologies use?

Minus sign iconPlus sign icon
Turn Biotechnologies's tech stack includes jQuery CDNSquarespaceGoogle Font APIChoicesOpen GraphRSSGoogleYouTube.

What is Turn Biotechnologies's email format?

Minus sign iconPlus sign icon
Turn Biotechnologies's email format typically follows the pattern of . Find more Turn Biotechnologies email formats with LeadIQ.

When was Turn Biotechnologies founded?

Minus sign iconPlus sign icon
Turn Biotechnologies was founded in 2018.
Turn Biotechnologies

Turn Biotechnologies

Biotechnology ResearchCalifornia, United States11-50 Employees

Aging has been called “the emperor of all maladies.” Turn Bio’s goal is to address multiple aging-related indications using a single powerful reprogramming therapy that turns old cells young again, aiding in the rejuvenation of an aged human body.

In 2013, a paper in Cell (The hallmarks of aging, López-Otin et al.,) proposed nine key “Hallmarks of Aging” that are causes of the general phenotype we refer to as “aging.” Our team recognized that it would be necessary to “turn back the clock” on each of these hallmarks and so set out to develop the technology to do just that. The task was achieved by a using a proprietary cocktail of transiently-administered rejuvenation factors that have now been shown to reverse eight of the nine hallmarks.

Join us as we embark on the task to "turn back time."​

Section iconCompany Overview

Headquarters
319 North Bernardo Ave Mountain View, California 94043 US
Website
turn.bio
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $10M

    Turn Biotechnologies's revenue is in the range of $10M

Section iconFunding & Financials

  • $10M

    Turn Biotechnologies's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.